[{"id":"4e8d1c5a-aa92-47e5-9dde-7cd5c8707088","acronym":"","url":"https://clinicaltrials.gov/study/NCT05756556","created_at":"2023-03-06T15:01:55.600Z","updated_at":"2024-07-02T16:35:21.279Z","phase":"Phase 2","brief_title":"T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma","source_id_and_acronym":"NCT05756556","lead_sponsor":"ImmVira Pharma Co. Ltd","biomarkers":" BRAF","pipe":" | ","alterations":" BRAF V600E • BRAF V600 • BRAF V600K • RAS mutation • BRAF V600E + BRAF V600K","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF V600E • BRAF V600 • BRAF V600K • RAS mutation • BRAF V600E + BRAF V600K"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Cotellic (cobimetinib) • T3011"],"overall_status":"Suspended","enrollment":" Enrollment 68","initiation":"Initiation: 06/30/2024","start_date":" 06/30/2024","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 01/01/2027","study_completion_date":" 01/01/2027","last_update_posted":"2024-02-01"},{"id":"b8562e47-8360-4e3a-9a00-3cb4c54257a3","acronym":"","url":"https://clinicaltrials.gov/study/NCT04370587","created_at":"2021-01-18T21:07:04.711Z","updated_at":"2024-07-02T16:35:38.768Z","phase":"Phase 1/2","brief_title":"A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT04370587","lead_sponsor":"ImmVira Pharma Co. Ltd","biomarkers":" EGFR • ALK","pipe":" | ","alterations":" ALK rearrangement","tags":["EGFR • ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALK rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • T3011"],"overall_status":"Recruiting","enrollment":" Enrollment 64","initiation":"Initiation: 09/17/2020","start_date":" 09/17/2020","primary_txt":" Primary completion: 10/31/2023","primary_completion_date":" 10/31/2023","study_txt":" Completion: 10/31/2025","study_completion_date":" 10/31/2025","last_update_posted":"2023-08-29"}]